Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors—Data From the ARON-1 Study Global Burden of Disease Study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results